HCRN-HN96-1

A Phase II Trial of Doxil in Advanced or Recurrent Head and Neck Cancer

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial HCRN-HN96-1 being conducted in.
No data was found